Related by context. Frequent words. (Click for all words.) 69 OSI Pharma 68 Metabasis Therapeutics 66 Rigel Pharmaceuticals 65 Teva Pharma 65 Transcept Pharmaceuticals 64 LGND 64 Meets Primary Endpoint 63 ACADIA Pharmaceuticals 63 Initiates Phase II 63 Presents Positive 63 Generic Version 63 CRTX 63 Cholesterol Drug 62 Vicuron Pharmaceuticals 62 Pivotal Phase III 62 Somaxon Pharmaceuticals 62 Above Consensus 62 FDA Accepts 62 Q2 Loss Narrows 62 Inc Therapeutic Competitors 62 BPAX 62 BioDelivery Sciences 62 Ziopharm 61 NBIX 61 DepoMed 61 Idenix Pharmaceuticals 61 gets USFDA nod 61 PHARMACEUTICALS 61 Sunesis Pharmaceuticals 61 Guides FY# 61 Drug Candidate 61 QLTI 61 Pharmos Corporation 61 DRRX 61 Backs FY# EPS 60 Completes Enrollment 60 Inc. Nasdaq IMGN 60 Penwest Pharmaceuticals 60 Flamel Technologies 60 Receives Orphan Drug Designation 60 Files Shelf Registration Statement 60 Array BioPharma 60 MLNM 60 Onyx Pharma 60 Idera Pharmaceuticals 60 Reaffirms Guidance 60 Lexicon Pharmaceuticals 60 Initiate Phase 60 Ardea Biosciences 59 CYTR 59 DVAX 59 Obstet Gynecol 59 Billion Share Repurchase 59 CardioVascular BioTherapeutics Inc. 59 Hana Biosciences 59 ENZN 59 Æterna Zentaris 59 Announces FDA Clearance 59 treat nicotine addiction 59 ISTA Pharmaceuticals 59 Halozyme Therapeutics 59 Endo Pharmaceuticals ENDP 59 Arch Neurol 59 Connetics Corporation 59 Anadys Pharmaceuticals 59 Opns 59 Option Grants 59 Cephalon NASDAQ CEPH 59 Completes Tender Offer 59 AEterna 59 NASDAQ SCLN 59 Clinical Trial Results 59 Threshold Pharmaceuticals 58 NovaBay Pharmaceuticals 58 MRNA 58 Phase III Clinical Trial 58 Endo Pharma 58 Adventrx 58 XTL Biopharmaceuticals Ltd. 58 4Q Loss Widens 58 Genelabs Technologies Inc. 58 Single Dose 58 Clinical Trials Update 58 Paladin Labs 58 Nasdaq REGN 58 NASDAQ CYPB 58 ALNY 58 SCLN 58 J Pediatr 58 Increases Share Repurchase 58 Ticagrelor 58 CADX 58 Improves Survival 58 Accentia Biopharmaceuticals 57 Progenics Pharmaceuticals 57 Cypress Bioscience 57 Venlafaxine 57 AMD# [002] 57 Altus Pharmaceuticals 57 Chemokine 57 Boosts Dividend